Bloomberg News
@Bloomberg-News·2.8M subscribers·40.1K videos
Coronavirus: U.K. Patient Gets First Pfizer-BioNTech Vaccine in the Western World
Posted
December 8, 2020
Views
7,091
Likes
182
Comments
366
Engagement
December 8, 2020
7,091
182
366
7.73%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
You’re on December 8, 2020. Earlier episodes are to the left, later ones to the right — the row keeps loading as you go. Click any card to open it.
Dec 8, 20201:17Now Playing90-year-old Margaret Keenan became the first person to get the Pfizer/BioNTech Covid-19 vaccine, with tens of thousands expected in coming days. U.K. health authorities began rolling out the first doses of the widely tested and independently reviewed Covid-19 vaccine on Tuesday, starting a global immunization program that is expected to gain momentum as more serums win approval.
Margaret Keenan turns 91 next week. The former jewelry shop assistant received the shot at University Hospital Coventry at 6:31am (6:31 GMT) while wearing a surgical mask and a blue Merry Christmas T-shirt decorated with a cartoon penguin wearing a Santa hat and red scarf.
The U.K. is getting a head start on the project after British regulators on December 2 gave emergency authorization to the vaccine produced by U.S. drugmaker Pfizer and Germany’s BioNTech.
U.S. and European Union authorities are also reviewing the vaccine, alongside rival products developed by U.S. biotechnology company Moderna, and a collaboration between Oxford University and drugmaker AstraZeneca.
The first shipments of the Pfizer/BioNTech vaccine were delivered to a selected group of U.K. hospitals on Sunday.
The vaccine can’t arrive soon enough for the U.K., which has more than 61,000 Covid-19-related deaths - more than any other country has reported in Europe. The U.K. has more than 1.7 million cases.
The 800,000 doses are only a fraction of what is needed. The government is targeting more than 25 million people, or about 40% of the population, in the first phase of its vaccination program, which gives first priority to those who are highest risk from the disease.
Subscribe to our YouTube channel
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
